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Evidence for Alteration of the Vitamin D-Endocrine System in Obese Subjects
Norman H. Bell, Sol Epstein, Anne Greene, Judith Shary, Mary Joan Oexmann, and Sheryl Shaw
Veterans Administration Medical Center and Departments ofMedicine and Pharmacology, Medical University ofSouth Carolina,
Charleston, South Carolina 29403; Albert Einstein Medical Center, Philadelphia, Pennsylvania 55901
Abstract
Serum immunoreactive parathyroid hormone (PTH) is increased
in obese as compared with nonobese subjects and declines with
weight loss. To determine whether alteration of the vitamin D-
endocrine system occurs in obesity and whether ensuing sec-
ondary hyperparathyroidism is associated with a reduction in
urinary calcium, a study was performed in 12 obese white
individuals, five men and seven women, and 14 nonobese white
subjects, eight men and six women, ranging in age from 20 to
35 yr. Body weight averaged 106±6 kg in the obese and 68±2
kg in the nonobese subjects (P < 0.01). Each of them were
hospitalized on a metabolic ward and were given a constant
daily diet containing 400 mg of calcium and 900 mg of
phosphorus. Whereas mean serum calcium, serum ionized
calcium, and serum phosphorus were the same in the two
groups, mean serum immunoreactive PTH (518±48 vs. 243±33
pg/ml, P <0.001), mean serum 1,25-dihydroxyvitamin D
I1,25(OH)2D] (37±2 vs. 29±2, P < 0.01), and mean serum
Gla protein (33±2 vs. 24±2 ng/ml, P < 0.02) were significantly
higher, and mean serum 25-hydroxyvitamin D (25-OHD) (8±1
vs. 20±2 ng/ml, P <0.001) was significantly lower in the
obese than in the nonobese men and women. Mean urinary
phosphorus was the same in the two groups, whereas mean
urinary calcium (115±10 vs. 166±13 mg/d, P < 0.01) was
significantly lower, and mean urinary cyclic AMP (3.18±0.43
vs. 1.84±0.25 nM/dl GF, P < 0.01) and creatinine clearance
(216±13 vs. 173±6 liter/d, P < 0.01) were significantly higher
in the obese than in the nonobese individuals. There was a
significant positive correlation between percentage of ideal
body weight and urinary cyclic AMP (r = 0.524, P < 0.01)
and between percentage of ideal body weight and serum
immunoreactive PTH (r = 0.717, P < 0.01) in the two groups.
The results provide evidence that alteration of the vitamin D-
endocrine system in obese subjects is characterized by secondary
hyperparathyroidism which is associated with enhanced renal
tubular reabsorption of calcium and increased circulating
1,25(OH)2D. The reduction of serum 25-OHD in them is
attributed to feedback inhibition of hepatic synthesis of the
precursor by the increased serum 1,25(OH)2D.
Introduction
Available evidence indicates that serum immunorea
thyroid hormone (PTH)1 is higher in obese than it
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young adults and declines with weight loss (1). In view of
these observations, we carried out an investigation to determine
whether obesity modifies the vitamin D-endocrine system and
whether secondary hyperparathyroidism is associated with a
reduction of urinary calcium in obese subjects.
Methods
26 normal white subjects were studied. There were 12 obese individuals
(five men and seven women) and 14 nonobese subjects (eight men
and six women) ranging in age from 20 to 35 yr. All of them were
hospitalized on the General Clinical Research Center of the Medical
University of South Carolina, Charleston, SC. They were given only
distilled water to drink and a constant daily diet that was estimated to
contain 400 mg of calcium, 900 mg of phosphorus, 18 meq of
magnesium, 110 meq of sodium, and 65 meq of potassium. Fasting
blood samples were collected for measurement of serum calcium,
ionized calcium, phosphorus, magnesium, creatinine, Gla protein, 25-
hydroxyvitamin D (25-OHD), 1,25-dihydroxyvitamin D [1,25(OH)2D],
and immunoreactive PTH. 24-h urines were collected for measurement
of calcium, phosphorus, sodium, potassium, magnesium, creatinine,
and cyclic AMP.
Serum and urinary calcium (2), phosphorus (3), creatinine (4), and
magnesium (5) were measured by automated colorimetric methods.
Serum ionized calcium was measured with a solid state ion electrode.
Urinary sodium and potassium were determined by flame photometer.
Serum 25-OHD was measured in duplicate at two concentrations by
competitive protein binding with vitamin D-deficient rat serum (6)
after extraction with acetonitrile, washing with phosphate buffer,
chromatography on C-18 Sep-Pak, and elution with acetonitrile (7).
25-OHD was separated from other vitamin D metabolites before the
binding assay by chromatography on silica Sep-Pak and elution with
hexane-propanol (94:6) (7). Serum 1,25(OH)2D was measured by the
method of Reinhardt et al. (7). Serum immunoreactive PTH was
measured by radioimmunoassay with a COOH-terminal specific anti-
body from chicken 77125 at a dilution of 1:10,000 (8). Serum Gla
protein was determined by radioimmunoassay (9). Urinary cyclic AMP
was measured by radioassay with a binding protein (10). Results are
expressed as nM/dl glomerular filtrate (GF) (11).
Statistical analyses were performed with nonpaired t test and
correlation coefficient by standard methods. The percentage of ideal
body weight was determined from tables of the Metropolitan Life
Insurance Company, New York.
Results
Weights of the obese and nonobese subjects averaged 106±6
tor. Address and 68±2 kg, respectively (P < 0.01). The mean age was
26±1 yr for the obese and 24±1 yr for the nonobese individuals.
_______ The results are summarized in Tables I and II and in Fig.
1. Mean serum Gla protein, mean serum immunoreactive
1. Abbreviations used in this paper: GF, glomerular filtrate; PTH,
parathyroid hormone.
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Table I. Serum Values in Obese and Nonobese White Subjects
Serum Serum Serum Serum Serum Serum Serum Serum
Subjects calcium Ca2+ phosphorus magnesium Gla protein* iPTHt 25-OHD 1,25(OH)2D
mg/dl mg/dl mg/dl meqiliter ng/ml pg/mi ng/ml pg/mi
Obese (12) 9.0±0.1 4.8±0.1 4.0±0.1 1.88±0.02 33±2 518±48 8±1 37±2
Nonobese (14) 9.0±0.1 4.8±0.1 3.9±0.2 1.85±0.04 24±3 243±33 20±2 29±2
P value NS NS NS NS <0.02 <0.001 <0.001 <0.01
Results are given as mean±SE. Figures in parentheses are the number of subjects. * Serum Gla protein was measured in 11 obese and 14
nonobese subjects. t Serum immunoreactive PTH (iPTH) was measured in 12 obese and 13 nonobese subjects.
PTH, and mean serum 1,25(OH)2D were significantly higher
in the obese as compared to the nonobese men and women
(Table I). Mean serum calcium, serum ionized calcium, serum
phosphorus, and serum magnesium were the same in the two
groups. Mean serum 25-OHD was significantly lower in the
obese than in the nonobese individuals. During the 2 d on the
constant diet, mean urinary calcium was significantly lower in
the obese than in the nonobese subjects (Table II). Mean
urinary cyclic AMP and creatinine clearance were significantly
higher in the obese subjects, and mean urinary phosphorus,
potassium, and magnesium were the same in the two groups.
As shown in Fig. 1, in all subjects there was a significant
positive correlation between percentage of ideal body weight
and urinary cyclic AMP (r = 0.524, P < 0.01). There was also
a significant positive correlation between percentage of ideal
body weight and serum immunoreactive PTH (r = 0.717, P
< 0.01).
Discussion
Bone mass is increased (12-18) and urinary calcium is dimin-
ished (19) in black as compared with white individuals. We
previously demonstrated increases in mean serum immuno-
reactive PTH, serum 1,25(OH)2D, and urinary cyclic AMP,
and confirmed that mean urinary calcium is reduced in normal
nonobese blacks (20). Further, the demonstration that the
blacks excreted an intravenous calcium load (15 mg calcium/
kg body weight infused over 8 h) as efficiently as whites
provided evidence that the reduction in urinary calcium in
blacks was caused by increases in circulating PTH and not by
primary enhancement of tubular reabsorption of the cation.
Mean serum Gla protein, an index of PTH status (21), was
lower in blacks than in whites, despite the higher circulating
PTH in the blacks. We interpreted these results to indicate
that modification of the vitamin D-endocrine system, with
enhanced renal tubular reabsorption of calcium and increased
circulating 1,25(OH)2D caused by increases in serum PTH,
may contribute to the greater bone mass in blacks (20). The
larger bone mass in them is attributed to increased muscle
mass (13).
The present findings in obese white subjects are similar to
the ones obtained by us in nonobese blacks. Thus, obese white
individuals show increases in mean serum immunoreactive
PTH (1), serum 1,25(OH)2D, and urinary cyclic AMP, and
decreases in urinary calcium as compared with nonobese white
men and women. The reduction of urinary calcium in the
obese individuals is all the more evident since it occurred
despite an average increase of 24.8% in creatinine clearance.
Obese postmenopausal women were found to have a lower
urinary calcium-to-creatinine ratio as compared with nonobese
postmenopausal women (22). One difference for which we
have no explanation is the reduction of serum Gla protein in
blacks in our previous study and the increase of serum Gla
protein in the obese as compared with nonobese white subjects,
which was seen in the present investigation. We interpret our
results to indicate that alteration of the vitamin D-endocrine
system also occurs in obesity, and is characterized by secondary
increases in circulating PTH with consequent enhanced tubular
reabsorption in calcium and increased renal production of
1,25(OH)2D.
An alternative explanation for our findings in obese men
and women is impaired intestinal absorption of calcium. This
possibility appears unlikely, since malabsorption of calcium, if
prolonged, would lead to a decline in bone mass. In this
Table II. Urinary Values in Obese and Nonobese White Subjects
Urinary Urinary Urinary Urinary Urinary Urinary Creatinine
Subjects calcium phosphorus sodium potassium magnesium cyclic AMP clearance
mg/d mg/d meqld meqld meqld nM/dI GF liter/d
Obese (12) 115±10 1,043±50 104±8 62±3 9.3±0.9 3.18±0.43 216±17
Nonobese (14) 166±13 938±37 124±8 62±4 9.2±0.4 1.84±0.25 173±6
P value <0.01 NS NS NS NS <0.01 <0.01
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Results are given as mean±SE of the average of two consecutive 24-h urine values in each subject. Figures in parentheses are the number of
subjects.
impaired production of 25-OHD in response to vitamin D
challenge described in the obese individuals (24). Low values
for serum 25-OHD were also observed in normal nonobese
black men and women in whom mean serum 1,25(OH)2D
was increased (20). It is likely that reduction of serum 25-
OHD in them results from impaired dermal production of
vitamin D because of increased skin pigment (27).
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Figure 1. Relationship between urinary cyclic AMP and percentage
of ideal body weight in obese and nonobese white subjects. In all of
them, there was a significant positive correlation between the two
determinations (r = 0.524, P < 0.01). *, nonobese; o, obese.
regard, measurement of bone mass in obese subjects has
yielded conflicting results. Radiographic measurements of
metacarpal cortical area showed that skeletal mass was greater
in obese than in age-matched nonobese subjects (23). On the
other hand, bone mass of the forearm determined by single-
photon absorptiometry demonstrated values that were within
the normal range (24). Urinary calcium-to-creatinine ratio in
obese postmenopausal women, which was reduced as compared
with values in nonobese postmenopausal women, correlated
negatively with serum estrogen, and serum estrogens were
shown to correlate with body weight (22). It is possible,
therefore, that increases in circulating estrogen that occur in
obesity because of increased peripheral conversion from an-
drogens, could modify the skeletal response to PTH in obese
women (22). It is unlikely, however, that this phenomenon
accounts for changes in the vitamin D-endocrine system
observed in obese men.
As noted already, increased bone mass in blacks is thought
to result from an increased muscle mass (13). If greater strain
on the skeleton produced by the increased body weight dimin-
ishes the skeletal response to PTH in obesity, the elevated
serum immunoreactive PTH should decline with weight loss.
Atkinson et al. (1) followed 27 massively obese subjects for
periods of up to 1 yr after jejunal-ileal intestinal bypass, and
noted that serum immunoreactive PTH decreased with weight
loss. Indeed, the reductions in body weight and serum immu-
noreactive PTH paralleled each other. Thus, at 6 mo after
surgery there was a significant correlation between the amount
of weight loss, which averaged 44 kg, and the decrease in
serum immunoreactive PTH (1).
Mean serum 25-OHD was lower in the obese than in the
nonobese subjects. A reduction in mean serum 25-OHD was
also found in two other groups of obese individuals, one of
which had undergone jejunal-ileal bypass (24, 25). In these
subjects, there was a progressive increase in serum 25-OHD
after surgery to values that were in the normal range. In view
of the present findings, and the previously described decline
in elevation of serum immunoreactive PTH in association
with weight loss after intestinal bypass (1), we attribute the
low serum 25-OHD in obese subjects to feedback inhibition
of hepatic synthesis of the metabolite by increased circulating
1,25(OH)2D (26). Reversal of obesity and elevated serum
immunoreactive PTH would lead to a decline in serum
1,25(OH)2D and allow serum 25-OHD to return to values in
the normal range. This explanation would also account for the
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